Results
Sandu Pharmaceuticals FY26 Results: Profit Growth, Dividend, AGM
Sandu Pharmaceuticals reported FY26 revenue of ₹69.93 crore with 23.2% net profit growth to ₹1.77 crore and recommended ₹1 per share dividend.
The company announced its 41st AGM on September 11, 2026
